Construction work in the insulin-active-ingredient production area could be completed by December and operational by March 2014. Lilly anticipates that construction-worker numbers would average around 70 and peak at around 160 during the proposed project. This portion of the investment would enable Lilly to increase its annual output of insulin active ingredient--the medicine that goes into the vials and cartridges that patients use.Once operational, approximately 175 full-time, highly skilled, specialized technicians, scientists, and engineers would be needed to manage operations in the cartridge-filling and insulin-active-ingredient manufacturing areas.
Potential Lilly Investment Would Further Expand Indianapolis Insulin Manufacturing Operations
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.